Anemia in Heart Failure: A Perspective from 20-Year Bibliometric Analysis

References

• Paulus WJ, Tschöpe C, Sanderson JE, et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the heart failure and echocardiography associations of the European society of cardiology. Eur Heart J. 2007;28(20):2539–2550. doi:10.1093/eurheartj/ehm037
   PubMed Web of Science ®Google Scholar
• Yancy CW, Jessup M, Bozkurt B, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American college of cardiology foundation/American heart association task force on practice guidelines. J Am Coll Cardiol. 2013;62(16):e147–e239. doi:10.1016/j.jacc.2013.05.019
   PubMed Web of Science ®Google Scholar
• Rossignol P, Hernandez AF, Solomon SD, Zannad F. Heart failure drug treatment. Lancet. 2019;393(10175):1034–1044. doi:10.1016/S0140-6736(18)31808-7
   PubMed Web of Science ®Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European society of cardiology (ESC) with the special contribution of the heart failure association (HFA) of the ESC. Eur Heart J. 2021;42(36):3599–3726. doi:10.1093/eurheartj/ehab368
   PubMed Web of Science ®Google Scholar
• James SL, Abate D, Abate KH, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–1858. doi:10.1016/S0140-6736(18)32279-7
   PubMed Web of Science ®Google Scholar
• van Riet EES, Hoes AW, Limburg A, Landman MAJ, van der Hoeven H, Rutten FH. Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion. Eur J Heart Fail. 2014;16(7):772–777. doi:10.1002/ejhf.110
   PubMed Web of Science ®Google Scholar
• Calvert MJ, Freemantle N, Cleland JGF. The impact of chronic heart failure on health-related quality of life data acquired in the baseline phase of the CARE-HF study. Eur J Heart Fail. 2005;7(2):243–251. doi:10.1016/j.ejheart.2005.01.012
   PubMed Web of Science ®Google Scholar
• Ziaeian B, Fonarow GC. Epidemiology and aetiology of heart failure. Nat Rev Cardiol. 2016;13(6):368–378. doi:10.1038/nrcardio.2016.25
   PubMed Web of Science ®Google Scholar
• Lawson CA, Zaccardi F, Squire I, et al. 20-year trends in cause-specific heart failure outcomes by sex, socioeconomic status, and place of diagnosis: a population-based study. Lancet Public Health. 2019;4(8):e406–e420. doi:10.1016/S2468-2667(19)30108-2
   PubMed Web of Science ®Google Scholar
• Janaswamy P, Walters TE, Nazer B, Lee RJ. Current treatment strategies for heart failure: role of device therapy and LV reconstruction. Curr Treat Options Cardiovasc Med. 2016;18(9):57. doi:10.1007/s11936-016-0479-1
   PubMedGoogle Scholar
• Tsao CW, Lyass A, Enserro D, et al. Temporal trends in the incidence of and mortality associated with heart failure with preserved and reduced ejection fraction. JACC Heart Fail. 2018;6(8):678–685. doi:10.1016/j.jchf.2018.03.006
   PubMed Web of Science ®Google Scholar
• Le CHH. The prevalence of anemia and moderate-severe anemia in the US population (NHANES 2003-2012). PLoS One. 2016;11(11):e0166635.
   PubMed Web of Science ®Google Scholar
• Stevens GA, Paciorek CJ, Flores-Urrutia MC, et al. National, regional, and global estimates of anaemia by severity in women and children for 2000-19: a pooled analysis of population-representative data. Lancet Glob Health. 2022;10(5):e627–e639. doi:10.1016/S2214-109X(22)00084-5
   PubMed Web of Science ®Google Scholar
• Culleton BF, Manns BJ, Zhang J, Tonelli M, Klarenbach S, Hemmelgarn BR. Impact of anemia on hospitalization and mortality in older adults. Blood. 2006;107(10):3841–3846. doi:10.1182/blood-2005-10-4308
   PubMed Web of Science ®Google Scholar
• Yusufu I, Cliffer IR, Yussuf MH, et al. Factors associated with anemia among school-going adolescents aged 10-17 years in Zanzibar, Tanzania: a cross sectional study. Bmc Public Health. 2023;23(1):1814. doi:10.1186/s12889-023-16611-w
   PubMedGoogle Scholar
• McLean E, Cogswell M, Egli I, Wojdyla D, de Benoist B. Worldwide prevalence of anaemia, WHO vitamin and mineral nutrition information system, 1993–2005. Public Health Nutr. 2009;12(4):444–454. doi:10.1017/S1368980008002401
   PubMed Web of Science ®Google Scholar
• Bianchi VE, von Haehling S. The treatment of chronic anemia in heart failure: a global approach. Clin Res Cardiol. 2023. doi:10.1007/s00392-023-02275-4
   PubMed Web of Science ®Google Scholar
• Anand IS, Gupta P. Anemia and iron deficiency in heart failure. Circulation. 2018;138(1):80–98. doi:10.1161/CIRCULATIONAHA.118.030099
   PubMed Web of Science ®Google Scholar
• Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes. Circulation. 2003;107(2):223–225. doi:10.1161/01.CIR.0000052622.51963.FC
   PubMed Web of Science ®Google Scholar
• Makubi A, Hage C, Sartipy U, et al. Heart failure in Tanzania and Sweden: comparative characterization and prognosis in the Tanzania Heart Failure (TaHeF) study and the Swedish Heart Failure Registry (SwedeHF). Int J Cardiol. 2016;220:750–758. doi:10.1016/j.ijcard.2016.06.239
   PubMed Web of Science ®Google Scholar
• Hassanein M, Abdelhamid M, Ibrahim B, et al. Clinical characteristics and management of hospitalized and ambulatory patients with heart failure–results from ESC heart failure long-term registry–Egyptian cohort. Esc Heart Fail. 2015;2(3):159–167. doi:10.1002/ehf2.12046
   PubMedGoogle Scholar
• Del Buono MG, Arena R, Borlaug BA, et al. Exercise Intolerance in patients with heart failure: JACC state-of-the-art review. J Am Coll Cardiol. 2019;73(17):2209–2225. doi:10.1016/j.jacc.2019.01.072
   PubMed Web of Science ®Google Scholar
• Cattadori G, Agostoni P, Corrà U, et al. Heart failure and anemia: effects on prognostic variables. Eur J Intern Med. 2017;37:56–63. doi:10.1016/j.ejim.2016.09.011
   PubMed Web of Science ®Google Scholar
• von Haehling S, Gremmler U, Krumm M, et al. Prevalence and clinical impact of iron deficiency and anaemia among outpatients with chronic heart failure: the PrEP Registry. Clin Res Cardiol. 2017;106(6):436–443. doi:10.1007/s00392-016-1073-y
   PubMed Web of Science ®Google Scholar
• Goh VJ, Tromp J, Teng TK, et al. Prevalence, clinical correlates, and outcomes of anaemia in multi-ethnic Asian patients with heart failure with reduced ejection fraction. Esc Heart Fail. 2018;5(4):570–578. doi:10.1002/ehf2.12279
   PubMed Web of Science ®Google Scholar
• Groenveld HF, Januzzi JL, Damman K, et al. Anemia and mortality in heart failure patients: a systematic review and meta-analysis. J Am Coll Cardiol. 2008;52(10):818–827. doi:10.1016/j.jacc.2008.04.061
   PubMed Web of Science ®Google Scholar
• Xia H, Shen H, Cha W, Lu Q. The prognostic significance of anemia in patients with heart failure: a meta-analysis of studies from the last decade. Front Cardiovasc Med. 2021;8:632318.
   PubMedGoogle Scholar
• Miao Y, Quan W, Dong X, et al. A bibliometric analysis of ferroptosis, necroptosis, pyroptosis, and cuproptosis in cancer from 2012 to 2022. Cell Death Discov. 2023;9(1):129. doi:10.1038/s41420-023-01421-1
   PubMed Web of Science ®Google Scholar
• Donthu N, Kumar S, Mukherjee D, Pandey N, Lim WM. How to conduct a bibliometric analysis: an overview and guidelines. J Bus Res. 2021;133:285–296. doi:10.1016/j.jbusres.2021.04.070
   Web of Science ®Google Scholar
• Ying H, Zhang X, He T, et al. A bibliometric analysis of research on heart failure comorbid with depression from 2002 to 2021. Heliyon. 2023;9(2). doi:10.1016/j.heliyon.2023.e13054
   Web of Science ®Google Scholar
• Yang Z, Zhong Z, Zhao C, et al. Global trends and frontiers in research on exercise training for heart failure: a bibliometric analysis from 2002 to 2022. Front Cardiovasc Med. 2023;10. doi:10.3389/fcvm.2023.1181600
   Web of Science ®Google Scholar
• Hirsch JE. An index to quantify an individual’s scientific research output. Proc Natl Acad Sci. 2005;102(46):16569–16572. doi:10.1073/pnas.0507655102
   PubMed Web of Science ®Google Scholar
• Chen C. CiteSpace II: detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57(3):359–377. doi:10.1002/asi.20317
   Web of Science ®Google Scholar
• Chen C, Ibekwe-SanJuan F, Hou J. The structure and dynamics of cocitation clusters: a multiple-perspective cocitation analysis. J Am Soc Inf Sci Technol. 2010;61(7):1386–1409. doi:10.1002/asi.21309
   Web of Science ®Google Scholar
• Qin Y, Zhang Q, Liu Y. Analysis of knowledge bases and research focuses of cerebral ischemia-reperfusion from the perspective of mapping knowledge domain. Brain Res Bull. 2020;156:15–24. doi:10.1016/j.brainresbull.2019.12.004
   PubMed Web of Science ®Google Scholar
• Freeman LC. Centrality in social networks conceptual clarification. Soc Networks. 1978;1(3):215–239. doi:10.1016/0378-8733(78)90021-7
   Web of Science ®Google Scholar
• Brandes U. A faster algorithm for betweenness centrality*. J Math Sociol. 2001;25(2):163–177. doi:10.1080/0022250X.2001.9990249
   Web of Science ®Google Scholar
• Chen C. Science Mapping: a Systematic Review of the Literature. J Data Info Sci. 2017;2(2):1–40. doi:10.1515/jdis-2017-0006
   Google Scholar
• Hunt SA. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association task force on practice guidelines (writing committee to update the 2001 guidelines for the evaluation and management of heart failure). J Am Coll Cardiol. 2005;46(6):e1–e82. doi:10.1016/j.jacc.2005.08.022
   PubMed Web of Science ®Google Scholar
• Maddox TM, Januzzi JL, Allen LA, et al. 2021 Update to the 2017 ACC expert consensus decision pathway for optimization of heart failure treatment: answers to 10 pivotal issues about heart failure with reduced ejection fraction: a report of the American College of Cardiology solution set oversight committee. J Am Coll Cardiol. 2021;77(6):772–810. doi:10.1016/j.jacc.2020.11.022
   PubMed Web of Science ®Google Scholar
• Siddiqi TJ, Anker SD, Filippatos G, et al. Health status across major subgroups of patients with heart failure and preserved ejection fraction. Eur J Heart Fail. 2023;25(9):1623–1631. doi:10.1002/ejhf.2831
   PubMed Web of Science ®Google Scholar
• Chioncel O, Benson L, Crespo-Leiro MG, et al. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational research programme heart failure long-term registry. Eur J Prev Cardiol. 2023;30(13):1346–1358. doi:10.1093/eurjpc/zwad151
   PubMed Web of Science ®Google Scholar
• Chopra VK, Anker SD. Anaemia, iron deficiency and heart failure in 2020: facts and numbers. Esc Heart Fail. 2020;7(5):2007–2011. doi:10.1002/ehf2.12797
   PubMed Web of Science ®Google Scholar
• Ferreira JP, Anker SD, Butler J, et al. Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR-Reduced. Eur J Heart Fail. 2022;24(4):708–715. doi:10.1002/ejhf.2409
   PubMed Web of Science ®Google Scholar
• Alnuwaysir RIS, Hoes MF, van Veldhuisen DJ, van der Meer P, Grote Beverborg N. Iron deficiency in heart failure: mechanisms and pathophysiology. J Clin Med. 2022;11(1):125.
   Web of Science ®Google Scholar
• Arcasoy MO. The non-haematopoietic biological effects of erythropoietin. Brit J Haematol. 2008;141(1):14–31. doi:10.1111/j.1365-2141.2008.07014.x
   PubMed Web of Science ®Google Scholar
• van der Meer P, Lipsic E, Henning RH, et al. Erythropoietin induces neovascularization and improves cardiac function in rats with heart failure after myocardial infarction. J Am Coll Cardiol. 2005;46(1):125–133. doi:10.1016/j.jacc.2005.03.044
   PubMed Web of Science ®Google Scholar
• van der Meer P, Voors AA, Lipsic E, van Gilst WH, van Veldhuisen DJ. Erythropoietin in cardiovascular diseases. Eur Heart J. 2004;25(4):285–291. doi:10.1016/j.ehj.2003.11.017
   PubMed Web of Science ®Google Scholar
• Sano M. A role of sodium-glucose co-transporter 2 in cardiorenal anemia iron deficiency syndrome. Int J Mol Sci. 2023;24(6):5983.
   PubMed Web of Science ®Google Scholar
• Anker SD, Butler J, Filippatos G, et al. Empagliflozin in heart failure with a preserved ejection fraction. New Engl J Med. 2021;385(16):1451–1461. doi:10.1056/NEJMoa2107038
   PubMed Web of Science ®Google Scholar
• Packer M, Anker SD, Butler J, et al. Cardiovascular and renal outcomes with empagliflozin in heart failure. New Engl J Med. 2020;383(15):1413–1424. doi:10.1056/NEJMoa2022190
   PubMed Web of Science ®Google Scholar
• Docherty KF, Curtain JP, Anand IS, et al. Effect of dapagliflozin on anaemia in DAPA-HF. Eur J Heart Fail. 2021;23(4):617–628. doi:10.1002/ejhf.2132
   PubMed Web of Science ®Google Scholar
• Metra M, Felker GM, Zacà V, et al. Acute heart failure: multiple clinical profiles and mechanisms require tailored therapy. Int J Cardiol. 2010;144(2):175–179. doi:10.1016/j.ijcard.2010.04.003
   PubMed Web of Science ®Google Scholar
• Hillege HL, Nitsch D, Pfeffer MA, et al. Renal function as a predictor of outcome in a broad spectrum of patients with heart failure. Circulation. 2006;113(5):671–678. doi:10.1161/CIRCULATIONAHA.105.580506
   PubMed Web of Science ®Google Scholar
• McCullough PA. Anemia of cardiorenal syndrome. Kidney Int Suppl. 2021;11(1):35–45. doi:10.1016/j.kisu.2020.12.001
   Web of Science ®Google Scholar
• Manla Y, Kholoki O, Bader F, et al. The prevalence of cardiorenal anemia syndrome among patients with heart failure and its association with all-cause hospitalizations: a retrospective single-center study from the Middle East. Front Cardiovasc Med. 2023;10.
   PubMed Web of Science ®Google Scholar
• Scrutinio D, Passantino A, Santoro D, Catanzaro R. The cardiorenal anaemia syndrome in systolic heart failure: prevalence, clinical correlates, and long-term survival. Eur J Heart Fail. 2011;13(1):61–67. doi:10.1093/eurjhf/hfq167
   PubMed Web of Science ®Google Scholar
• Lu KJ, Kearney LG, Hare DL, et al. Cardiorenal anemia syndrome as a prognosticator for death in heart failure. Am J Cardiol. 2013;111(8):1187–1191. doi:10.1016/j.amjcard.2012.12.049
   PubMed Web of Science ®Google Scholar
• Kim CJ, Choi I, Park H, et al. Impact of cardiorenal anemia syndrome on short- and long-term clinical outcomes in patients hospitalized with heart failure. Cardiorenal Med. 2016;6(4):269–278. doi:10.1159/000443339
   PubMed Web of Science ®Google Scholar
• Pallangyo P, Fredrick F, Bhalia S, et al. Cardiorenal anemia syndrome and survival among heart failure patients in Tanzania: a prospective cohort study. Bmc Cardiovasc Disor. 2017;17(1):59. doi:10.1186/s12872-017-0497-2
   PubMedGoogle Scholar
• Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37(27):2129–2200. doi:10.1093/eurheartj/ehw128
   PubMed Web of Science ®Google Scholar
• Ponikowski P, van Veldhuisen DJ, Comin-Colet J, et al. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†. Eur Heart J. 2015;36(11):657–668. doi:10.1093/eurheartj/ehu385
   PubMed Web of Science ®Google Scholar
• Cappellini MD, Comin-Colet J, de Francisco A, et al. Iron deficiency across chronic inflammatory conditions: international expert opinion on definition, diagnosis, and management. Am J Hematol. 2017;92(10):1068–1078. doi:10.1002/ajh.24820
   PubMed Web of Science ®Google Scholar
• Tang Y, Katz SD. Anemia in chronic heart failure. Circulation. 2006;113(20):2454–2461. doi:10.1161/CIRCULATIONAHA.105.583666
   PubMed Web of Science ®Google Scholar
• Mancini DM, Katz SD, Lang CC, LaManca J, Hudaihed A, Androne A. Effect of erythropoietin on exercise capacity in patients with moderate to severe chronic heart failure. Circulation. 2003;107(2):294–299. doi:10.1161/01.CIR.0000044914.42696.6A
   PubMed Web of Science ®Google Scholar
• Qunibi WY. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review. Arzneimittelforschung. 2010;60(06):399–412. doi:10.1055/s-0031-1296304
   PubMedGoogle Scholar
• Anand IS. Anemia and chronic heart failure: implications and treatment options. J Am Coll Cardiol. 2008;52(7):501–511. doi:10.1016/j.jacc.2008.04.044
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Iaina A, Steinbruch S, Wollman Y, Schwartz D. Anemia, chronic renal disease and congestive heart failure—the cardio renal anemia syndrome: the need for cooperation between cardiologists and nephrologists. Int Urol Nephrol. 2006;38(2):295–310. doi:10.1007/s11255-006-0064-8
   PubMed Web of Science ®Google Scholar
• Silverberg DS, Wexler D, Blum M, et al. The effect of correction of anaemia in diabetics and non‐diabetics with severe resistant congestive heart failure and chronic renal failure by subcutaneous erythropoietin and intravenous iron. Nephrol Dial Transpl. 2003;18(1):141–146. doi:10.1093/ndt/18.1.141
   PubMed Web of Science ®Google Scholar
• Tonelli M, Sacks F, Arnold M, Moye L, Davis B, Pfeffer M. Relation between red blood cell distribution width and cardiovascular event rate in people with coronary disease. Circulation. 2008;117(2):163–168. doi:10.1161/CIRCULATIONAHA.107.727545
   PubMed Web of Science ®Google Scholar
• Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti L. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state. Am Heart J. 2009;158(4):659–666. doi:10.1016/j.ahj.2009.07.024
   PubMed Web of Science ®Google Scholar
• Pascual-Figal DA, Bonaque JC, Redondo B, et al. Red blood cell distribution width predicts long-term outcome regardless of anaemia status in acute heart failure patients. Eur J Heart Fail. 2009;11(9):840–846. doi:10.1093/eurjhf/hfp109
   PubMed Web of Science ®Google Scholar
• Wołowiec A, Rogowicz D, Banach J, et al. Prognostic significance of red cell distribution width and other red cell parameters in patients with chronic heart failure during two years of follow-up. Kardiologia Polska. 2016;74(7):657–664. doi:10.5603/KP.a2016.0004
   PubMed Web of Science ®Google Scholar
• Rahamim E, Zwas DR, Keren A, et al. The ratio of hemoglobin to red cell distribution width: a strong predictor of clinical outcome in patients with heart failure. J Clin Med. 2022;11(3):886.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Am J Resp Crit Care. 2013;187(4):347–365. doi:10.1164/rccm.201204-0596PP
   PubMed Web of Science ®Google Scholar
• Rigatto C, Parfrey P, Foley R, Negrijn C, Tribula C, Jeffery J. Congestive heart failure in renal transplant recipients: risk factors, outcomes, and relationship with ischemic heart disease. J Am Soc Nephrol. 2002;13(4):1084–1090.
   PubMed Web of Science ®Google Scholar
• Moore J, He X, Cockwell P, Little MA, Johnston A, Borrows R. The impact of hemoglobin levels on patient and graft survival in renal transplant recipients. Transplantation. 2008;86(4):564–570.
   PubMed Web of Science ®Google Scholar
• Salisbury AC, Kosiborod M. Hospital-acquired anemia in patients with cardiovascular disease: incidence, outcomes, and opportunities for prevention. Rcm. 2012;13(4):150–160.
   Google Scholar
• McDonagh TA, Metra M, Adamo M, et al. 2023 Focused update of the 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: developed by the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2023;44(37):3627–3639. doi:10.1093/eurheartj/ehad195
   PubMed Web of Science ®Google Scholar
• Guralnik JM, Eisenstaedt RS, Ferrucci L, Klein HG, Woodman RC. Prevalence of anemia in persons 65 years and older in the United States: evidence for a high rate of unexplained anemia. Blood. 2004;104(8):2263–2268. doi:10.1182/blood-2004-05-1812
   PubMed Web of Science ®Google Scholar
• Dunlay SM, Weston SA, Redfield MM, Killian JM, Roger VL. Anemia and heart failure: a community study. Am j Med. 2008;121(8):726–732. doi:10.1016/j.amjmed.2008.03.039
   PubMed Web of Science ®Google Scholar
• Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure. Circulation. 2006;113(23):2713–2723. doi:10.1161/CIRCULATIONAHA.105.577577
   PubMed Web of Science ®Google Scholar
• Kosiborod M, Curtis JP, Wang Y, et al. Anemia and outcomes in patients with heart failure: a study from the national heart care project. Archives of Internal Medicine. 2005;165(19):2237–2244. doi:10.1001/archinte.165.19.2237
   PubMedGoogle Scholar
• Makubi A, Roberts DJ. Investigation and treatment for iron deficiency in heart failure: the unmet need in lower and middle income countries. Brit J Haematol. 2017;177(6):896–904. doi:10.1111/bjh.14650
   PubMed Web of Science ®Google Scholar